MCID: RBL001
MIFTS: 57

Rubella malady

Categories: Rare diseases, Infectious diseases, Fetal diseases, Neuronal diseases

Aliases & Classifications for Rubella

About this section

Summaries for Rubella

About this section
MedlinePlus:38 Rubella is an infection caused by a virus. it is usually mild with fever and a rash. about half of the people who get rubella do not have symptoms. if you do get them, symptoms may include a rash that starts on the face and spreads to the body mild fever aching joints, especially in young women swollen glands rubella is most dangerous for a pregnant woman's baby. it can cause miscarriage or birth defects. rubella spreads when an infected person coughs or sneezes. people without symptoms can still spread it. there is no treatment, but the measles-mumps-rubella (mmr) vaccine can prevent it. centers for disease control and prevention

MalaCards based summary: Rubella, also known as german measles, is related to hepatitis and aseptic meningitis, and has symptoms including exanthema, fever and pruritus. An important gene associated with Rubella is CD40LG (CD40 Ligand), and among its related pathways are Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell and Antigen Presentation- Folding, assembly and peptide loading of class I MHC. Affiliated tissues include skin, skin and eye, and related mouse phenotype Increased shRNA abundance.

CDC:2 Rubella is a contagious disease caused by a virus. Most people who get rubella usually have a mild illness, with symptoms that can include a low-grade fever, sore throat, and a rash that starts on the face and spreads to the rest of the body. Rubella can cause a miscarriage or serious birth defects in an developing baby if a woman is infected while she is pregnant. The best protection against rubella is MMR (measles-mumps-rubella) vaccine.

Disease Ontology:11 A viral infectious disease that results in infection located in skin, has material basis in Rubella virus, which is transmitted by droplet spread of oronasal secretions from the infected person through coughing and sneezing, and transmitted by congenital method. The infection has symptom rash on the face which spreads to the trunk and limbs, has symptom fever, has symptom lymphadenopathy, has symptom joint pains, has symptom headache, and has symptom conjunctivitis.

Wikipedia:71 Rubella, also known as German measles or three-day measles, is an infection caused by the rubella virus.... more...

Related Diseases for Rubella

About this section

Diseases in the Rubella family:

Congenital Rubella

Diseases related to Rubella via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50)    (show all 252)
idRelated DiseaseScoreTop Affiliating Genes
1hepatitis30.1HLA-A, HLA-B, HLA-DRB1, TNF
2aseptic meningitis30.0HLA-A, HLA-B, HLA-DRB1, TNF
3tuberculosis29.3CD40LG, IL4, TNF
4status epilepticus29.3IL4, MOG, TNF
5congenital rubella12.5
6rubella panencephalitis11.9
7primary immunodeficiency with post-measles-mumps-rubella vaccine viral infection11.8
8measles11.5
9mumps11.3
10acute disseminated encephalomyelitis11.2
11cytomegalic inclusion disease11.0
12microcephaly10.9
13infections, recurrent, with encephalopathy, hepatic dysfunction, and cardiovasuclar malformations10.7
14acute hemorrhagic leukoencephalitis10.7
15togaviridae disease10.7
16immune-mediated encephalomyelitis10.7
17postinfectious encephalomyelitis10.7
18apple allergy10.3HLA-DQB1, HLA-DRB1
19hemoglobin d disease10.3HLA-DQB1, HLA-DRB1
20solid pseudopapillary carcinoma of pancreas10.3HLA-A, HLA-B
21caplan's syndrome10.2HLA-DPB1, HLA-DRB1
22lin-gettig syndrome10.2HLA-DQB1, HLA-DRB1
23midline interhemispheric variant of holoprosencephaly10.2HLA-DQB1, HLA-DRB1
24myopathy, congenital nonprogressive, with moebius sequence and robin sequence10.2HLA-A, HLA-B
25hypopituitarism10.2CD40LG, HLA-B, HLA-DPB1
26niemann-pick disease10.2HLA-DPB1, HLA-DRB1, MOG
27tubular renal disease-cardiomyopathy syndrome10.2IL4, TNF
28rete testis adenocarcinoma10.2HLA-A, HLA-DQB1
29immune deficiency, familial variable10.2HLA-B, HLA-DQB1, HLA-DRB1
30epididymo-orchitis10.2HLA-A, HLA-B
31human immunodeficiency virus infectious disease10.2CD40LG, HLA-DRB1, TNF
32pancreatic signet ring cell adenocarcinoma10.2CD40LG, HLA-DRB1, TNF
33autosomal dominant intermediate charcot-marie-tooth10.2HLA-DQB1, HLA-DRB1, TNF
34hereditary alpha tryptasemia syndrome10.2CD40LG, HLA-DRB1, TNF
35benign deep fibrous histiocytoma10.2CD40LG, HLA-DRB1, TNF
36endogenous depression10.2CD40LG, HLA-DRB1, TNF
37plummer's disease10.2CD40LG, HLA-DRB1, TNF
38pulmonary hemosiderosis10.2HLA-DRB1, MOG, TNF
39anthracosis10.2CD40LG, HLA-A, HLA-DPB1
40t-cell prolymphocytic leukemia10.2HLA-DQB1, TNF
41immunoglobulin g deficiency10.2CD40LG, HLA-DRB1, TNF
42lagophthalmos10.2IL4, TNF
43myeloid and lymphoid neoplasms with eosinophilia and abnormalities of pdgfra, pdgfrb, and fgfr110.2HLA-B, HLA-DQB1, TNF
44low anorectal malformation10.2HLA-DQB1, HLA-DRB1, TNF
45mirizzi syndrome10.2HLA-B, HLA-DRB1, TNF
46diabetic angiopathy10.2CD40LG, IL4
47barbiturate abuse10.2CD40LG, HLA-DQB1, IL4
48swine influenza10.1HLA-B, HLA-DRB1, TNF
49celiac disease10.1CD40LG, HLA-B, TNF
50sacral nerve root cysts10.1HLA-A, HLA-B, HLA-DRB1

Graphical network of the top 20 diseases related to Rubella:



Diseases related to rubella

Symptoms & Phenotypes for Rubella

About this section

Symptoms:

 11 (show all 6)
  • rash on the face which spreads to the trunk
  • fever
  • lymphadenopathy
  • joint pains
  • headache
  • conjunctivitis

UMLS symptoms related to Rubella:


exanthema, fever, pruritus

GenomeRNAi Phenotypes related to Rubella according to GeneCards Suite gene sharing:

26
idDescriptionGenomeRNAi Source AccessionScoreTop Affiliating Genes
1GR00327-A8.3HLA-B, HLA-DPB1, HLA-DQB1, IL4

Drugs & Therapeutics for Rubella

About this section

Drugs for Rubella (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50)    (show all 62)
idNameStatusPhaseClinical TrialsCas NumberPubChem Id
1VaccinesPhase 4, Phase 2, Phase 3, Phase 1, Early Phase 16611
2AntibodiesPhase 4, Phase 2, Phase 16394
3ImmunoglobulinsPhase 4, Phase 2, Phase 16394
4Pharmaceutical SolutionsPhase 4, Phase 3, Phase 28192
5Heptavalent Pneumococcal Conjugate VaccinePhase 4, Phase 3, Phase 2465
6Liver ExtractsPhase 44067
7
Tetracyclineapproved, vet_approvedPhase 3, Phase 210560-54-85353990
Synonyms:
(-)-Tetracycline
(4S,4AS,5as,12as)-4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,6,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-2-naphthacenecarboxamide
6-Methyl-1,11-dioxy-2-naphthacenecarboxamide
60-54-8
64-75-5 (mono-hydrochloride)
6591-49-7
87128_FLUKA
87128_SIGMA
AC-13151
AC1L1KAT
AC1NQXT7
AC1NRDAM
AC1NS4RQ
AC1NSDX8
AC1NTUT2
AC1NUZHL
AC1O52HS
Abramycin
Abricycline
Achromycin
Achromycin (naphthacene derivative)
Achromycin V
Achromycin, naphthacene derivative
Agromicina
Ambramicina
Ambramycin
Amycin
Anhydrotetracycline
BIDD:GT0653
BPBio1_000242
BSPBio_000220
BSPBio_001950
Bio-tetra
Biocycline
Bristaciclin
Bristaciclin .alpha.
Bristaciclina
Bristacycline
C06570
CHEBI:27902
CHEMBL1440
CID12309720
CID5280962
CID5289435
CID5353990
CID5359245
CID5388997
CID5412
CID5497101
CID6426717
Cefracycline
Cefracycline suspension
Centet (base)
Ciclibion
Copharlan
Criseociclina
Cyclomycin
Cyclopar
Cytome
D00201
DB00759
Democracin
Deschlorobiomycin
DivK1c_000827
Dumocyclin
EINECS 200-481-9
Enterocycline
HMS2090B04
HSDB 3188
Hostacyclin
IDI1_000827
KBio1_000827
KBio2_001514
KBio2_004082
KBio2_006650
KBio3_001450
KBioGR_000783
KBioSS_001514
LS-187078
LS-93869
Lemtrex (base)
Lexacycline
Limecycline
Liquamycin
Liquamycin (Veterinary)
 
Liquamycin, veterinary
MLS000069728
Medocycline
Mericycline
Micycline
MolPort-001-794-633
MolPort-003-983-460
MolPort-005-934-198
NCGC00161665-01
NINDS_000827
NSC 108579
NSC108579
Neocycline
Omegamycin
Orlycycline
Panmycin
Piracaps (base)
Polycycline
Polycycline (VAN)
Polycycline (antibiotic)
Polycycline, antibiotic
Polyotic
Prestwick0_000140
Prestwick1_000140
Prestwick2_000140
Prestwick3_000140
Purocyclina
Resteclin
Robitet
Roviciclina
SK-Tetracycline
SMR000058220
SPBio_001457
SPBio_002159
STOCK1N-42738
Sanclomycine
Solvocin
Spectrum2_001329
Spectrum3_000565
Spectrum4_000352
Spectrum5_001112
Spectrum_001034
Sumycin
Sumycin (TN)
Sumycin syrup
T-125
T3258_SIGMA
Tetra-Co
Tetrabon
Tetrachel
Tetraciclina
Tetraciclina [INN-Spanish]
Tetracycl
Tetracyclin
Tetracycline & VRC3375
Tetracycline (JAN/USP/INN)
Tetracycline (internal use)
Tetracycline Free Base
Tetracycline HCl
Tetracycline I
Tetracycline II
Tetracycline Monohydrochloride
Tetracycline [USAN:INN:BAN:JAN]
Tetracyclinum
Tetracyclinum [INN-Latin]
Tetracyn
Tetradecin
Tetrafil
Tetraverine
Tetrazyklin
Topicycline
Tsiklomistsin
Tsiklomitsin
Tétracycline
UNII-F8VB5M810T
UPCMLD-DP127
UPCMLD-DP127:001
UPCMLD-DP127:002
Veracin
Vetacyclinum
Vetquamycin-324 (free base)
WLN: L E6 C666 BV FV CU GUTTT&J DQ EQ GVZ HQ IN1&1 MQ M1 RQ
component of Tetrastatin
methyl-1,11-dioxo-2-naphthacenecarboxamide
nchembio.273-comp1
nchembio.289-comp1
tetracycline
8
Aluminum hydroxideapprovedPhase 3, Phase 221021645-51-2
Synonyms:
Al(OH)3
Aluminium hydroxide
Aluminium hydroxide gel, dried
 
Aluminium hydroxide, dried
Aluminum hydroxide gel, dried
Aluminum hydroxide, dried
Dried aluminium hydroxide
Dried aluminum hydroxide gel
9
Vitamin Aapproved, nutraceutical, vet_approvedPhase 349211103-57-4, 68-26-8445354
Synonyms:
(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraen-1-ol
(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2,4,6,8-tetraen-1-ol
(all-E)-3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraen-1-ol
.alpha.lin
.alpha.sterol
.beta.-Retinol
11103-57-4
13123-33-6
1341-18-0
1406-67-3
17104-91-5
1rbp
3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclchexen-1-yl)-2,4,6,8-nonatetraen-1-ol
3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonate-traen-1-ol
3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraen-1-ol
3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexenyl)-2,4,6,8-nonatetraen-1-ol
3,7-dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraen-1-ol, (all-E)-Isomer
4-06-00-04133 (Beilstein Handbook Reference)
53637-36-8
5979-23-7
68-26-8
95144_FLUKA
95144_SIGMA
95146_FLUKA
95146_SIGMA
A-Mulsal
A-Sol
A-Vi-Pel
A-Vitan
AC-11701
AC1L9HU3
AC1Q7BU9
ACON
ALL-TRANS RETINOL (SEE ALSO RETINOID PROJECT 1)
AR-1L3057
ATAV
Afaxin
Agiolan
Agoncal
Alcohol 9,13-dimethyl-7-(1,1,5-trimethyl-6-cyclohexen-5-yl)-7,9,11,13-nonatetraen-15-ol
Alcovit A
All Trans Retinol
All-trans retinol
All-trans-Retinol
Alphalin
Alphasterol
Anatola
Anatola A
Anti-infective vitamin
Antixerophthalmic vitamin
Antixerophthalmisches Vitamin
Aoral
Apexol
Apostavit
Aquasol A Parenteral
Aquasynth
Atars
Avibon
Avita
Avitol
Axerol
Axerophthol
Axerophtholum
BIDD:PXR0102
BRN 0403040
Bentavit A
Biosterol
C00473
C17276
C20H30O
CCRIS 5444
CHEBI:17336
CHEMBL986
CID445354
Chocola A
Cylasphere
D014801
D06543
DB00162
Del-VI-A
Disatabs Tabs
Dofsol
Dohyfral A
EINECS 200-683-7
EINECS 234-328-2
Epiteliol
HMS1921B04
HMS2092L13
HMS501I08
HSDB 815
Hi-A-Vita
Homagenets Aoral
Homagenets aorl
Hydrovit A
IDI1_000486
LMPR01090001
LPK
LS-1578
Lard Factor
M.V.C. 9+3
M.V.I.-12
 
MLS001066379
MLS001074751
MolPort-001-785-962
Mvc Plus
Myvpack
NCGC00091784-01
NCGC00091784-02
NCGC00091784-03
NCGC00091784-04
NCGC00091784-05
NCGC00091784-06
NSC 122759
NSC122759
Nio-A-Let
Oleovitamin A
Ophthalamin
Plivit A
Prepalin
R7632_SIGMA
Retin-11,12-t2-ol (9CI)
Retinol
Retinol [INN:BAN]
Retinol solution
Retinol, all-trans- (8CI)
Retinol-(cellular-retinol-binding-protein)
Retinolo
Retinolo [DCIT]
Retinolum
Retinolum [INN-Latin]
Retrovitamin A
Ro-a-vit
Rovimix A 500
SDCCGMLS-0066724.P001
SMP2_000102
SMR000112036
SPECTRUM1501203
ST057232
Sehkraft A
Solu-A
Spectrum5_000993
Spectrum5_001997
Super A
Testavol
Testavol S
Thalasphere
UNII-81G40H8B0T
UNII-G2SH0XKK91
Vaflol
Vafol
Veroftal
Vi-.alpha.
Vi-Alpha
Vi-Dom-A
Vi-a
Vio-A
Vitamin A
Vitamin A (Feed)
Vitamin A (USP)
Vitamin A alcohol
Vitamin A alcohol (VAN)
Vitamin A cryst
Vitamin A1
Vitamin A1 alcohol
Vitamin A1 alcohol, all trans
Vitamin- A
Vitamin- A alcohol
Vitamin- A alcohol solution
Vitamin- A1
Vitamin-?A
Vitamin-?A alcohol
Vitamin-?A alcohol solution
Vitamin-?A1
Vitamine A
Vitaminum A
Vitavel A
Vitavel-A
Vitpex
Vogan
Vogan-Neu
Vogan-nu
WLN: L6UTJ A1 B1U1Y1&U2U1Y1&U2Q C1 C1
Wachstumsvitamin
ZINC03831417
Zinosan N
[11,12-3H]-Retinol
alin
all-trans-3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraen-1-ol
all-trans-Retinol
all-trans-Retinyl alcohol
all-trans-Vitamin A
all-trans-Vitamin A alcohol
all-trans-Vitamin A1
all-trans-retinol
all-trans-retinyl alcohol
all-trans-vitamin A alcohol
b-Retinol
beta-Retinol
retinol
tROL
trans-Retinol
trans-Retinol acid (Vitamin A)
trans-Vitamin A alcohol
trans-retinol
10
LactitolPhase 3, Phase 2336585-86-43871
Synonyms:
4-O-b-D-Galactopyranosyl-D-glucitol, 9CI
E966
Emportal
 
Floralac
Importal
Oponaf
Portolac
11PENTAPhase 3, Phase 2109
12Anti-Infective AgentsPhase 3, Phase 222062
13Anti-Bacterial AgentsPhase 3, Phase 211226
14Retinol palmitatePhase 3492
15VitaminsPhase 35282
16Trace ElementsPhase 36001
17AntioxidantsPhase 33050
18Protective AgentsPhase 3, Phase 27443
19MicronutrientsPhase 36001
20retinolNutraceuticalPhase 3492
21
AltretamineapprovedPhase 265645-05-62123
Synonyms:
2,4, 6-Tris(dimethylamino)-1,3,5-triazine
2,4,6-Tris(dimethylami
2,4,6-Tris(dimethylamino)-1,3,5-triazine
2,4,6-Tris(dimethylamino)-S-triazine
2,4,6-Tris(dimethylamino)-s-triazine
2-N,2-N,4-N,4-N,6-N,6-N-hexamethyl-1,3,5-triazine-2,4,6-triamine
549835_ALDRICH
645-05-6
A 8723
A0567/0026158
A8723_SIGMA
AB00052308
AC-12006
AC1L1CYX
AI3-50852
AKOS001729401
Altretamin
Altretamina
Altretamina [INN-Spanish]
Altretamine (USP/INN)
Altretamine Bellon Brand
Altretamine Chiesi Brand
Altretamine Wassermann Brand
Altretamine [USAN:INN:BAN]
Altretaminum
Altretaminum [INN-Latin]
Altrétamine
BPBio1_001004
BRD-K67043667-001-04-1
BRN 0195058
BSPBio_000912
Bellon Brand of Altretamine
C9H18N6
CAS-654-05-6
CCRIS 5492
CHEBI:24564
CHEMBL1455
CID2123
CPD000058181
ChemDiv2_005185
Chiesi Brand of Altretamine
D006585
D02841
DB00488
DivK1c_000772
EINECS 211-428-4
ENT 50852
EU-0100083
FT-0083576
HEXAMETHYLMELAMINE
HMM
HMS1383L15
HMS1570N14
HMS1922C05
HMS2090G17
HMS2092H16
HMS502G14
HSDB 7559
HTM
HXM
Hemel
Hexalen
Hexalen (TN)
Hexalen, Altretamine
 
Hexamethylmelamine
Hexastat
Hexinawas
I06-0604
IDI1_000772
IDI1_003900
InChI=1/C9H18N6/c1-13(2)7-10-8(14(3)4)12-9(11-7)15(5)6/h1-6H
KB-913
KBio1_000772
KBio2_001788
KBio2_004356
KBio2_006924
KBio3_002042
KBioGR_001388
KBioSS_001788
LS-1549
Lopac-A-8723
Lopac0_000083
MGI Pharma Brand of Altretamine
MLS000069621
MLS001076123
MolPort-002-111-210
N,N,N',N',N'',N''-hexamethyl-1,3,5-triazine-2,4,6-triamine
NC 195
NCGC00015100-01
NCGC00015100-02
NCGC00015100-03
NCGC00015100-06
NCGC00015100-11
NCGC00021216-03
NCGC00021216-04
NCGC00021216-05
NCGC00021216-06
NCGC00021216-07
NCI-C50259
NCI60_000871
NINDS_000772
NSC 13875
NSC-13875
NSC13875
N~2~,N~2~,N~4~,N~4~,N~6~,N~6~-Hexamethyl-1,3,5-triazine-2,4,6-triamine
Prestwick0_000946
Prestwick1_000946
Prestwick2_000946
Prestwick3_000946
Rhone Poulenc Rorer Brand of Altretamine
Rhone-Poulenc Rorer Brand of Altretamine
S1278_Selleck
SAM002564241
SMR000058181
SPBio_000754
SPBio_003071
SPECTRUM1503065
ST086739
STK749184
Spectrum2_000907
Spectrum3_000951
Spectrum4_001064
Spectrum5_001092
Spectrum_001308
UNII-Q8BIH59O7H
WLN: T6N CN ENJ BN1&1 DN1&1 FN1&1
Wassermann Brand of Altretamine
ZINC00000905
altretamine
no)-s-triazine
22
Mycophenolic acidapprovedPhase 295224280-93-1446541
Synonyms:
(e)-6-(4-Hydroxy-6-methoxy-7-methyl-3-oxo-5-phthalanyl)-4-methyl-4-hexenoic acid
Acide mycophenolique
Acido micofenolico
Acidum mycophenolicum
 
Melbex
Micofenolico acido
Mycophenoic acid
Mycophenolate
Mycophenolsäure
Myfortic
23
Mycophenolate mofetilapproved, investigationalPhase 2952128794-94-55281078
Synonyms:
115007-34-6
128794-94-5
140401-05-4
2-Morpholinoethyl (4E)-6-(4-hydroxy-6-methoxy-7-methyl-3-oxo-5-phthalanyl)-4-methyl-4-hexenoate
2-Morpholinoethyl (E)-6-(4-hydroxy-6-methoxy-7-methyl-3-oxo-5-phthalanyl)-4-methyl-4-hexenoate
2-Morpholinoethyl (e)-6-(4-hydroxy-6-methoxy-7-methyl-3-oxo-5-phthalanyl)-4-methyl-4-hexenoate
2-morpholin-4-ylethyl (4E)-6-[4-hydroxy-7-methyl-6-(methyloxy)-3-oxo-1,3-dihydro-2-benzofuran-5-yl]-4-methylhex-4-enoate
2-morpholin-4-ylethyl (E)-6-(4-hydroxy-6-methoxy-7-methyl-3-oxo-1H-2-benzofuran-5-yl)-4-methylhex-4-enoate
4-Hexenoic acid, 6-(1,3-dihydro-4-hydroxy-6-methoxy-7-methyl -3-oxo-5-isobenzofuranyl)-4-methyl-, 2-(4-morpholinyl)ethyl ester, (4E)
AC-1562
AC1NQXZW
AC1Q6O6X
AR-1J6939
BB_NC-2566
C07908
C23H31NO7
CHEMBL1456
CID5281078
CellCept
CellCept, RS 61443, TM-MMF, Mycophenolate mofetil
Cellcept
Cellcept (TN)
D00752
DB00688
HMS2090A03
 
HSDB 7436
I01-0898
I06-1947
LS-172272
LS-75572
ME-MPA
MMF
MMF CellCept(TM)
MolPort-000-883-800
Munoloc
Mycophenolate mofetil (JAN/USAN)
Mycophenolic acid morpholinoethyl ester
Mycophenylate mofetil
NCGC00159459-02
NCGC00159459-03
NSC724229
R-99
RS 61443
RS-61443
RS-61443-190
S1501_Selleck
TL8000648
TM-MMF
UNII-9242ECW6R0
ZINC21297660
mycophenolate mofetil
24
ObinutuzumabapprovedPhase 2, Phase 1105949142-50-1
Synonyms:
 
Afutuzumab
25
Methylprednisoloneapproved, vet_approvedPhase 2119383-43-26741
Synonyms:
(6S,8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-17-(2-hydroxyacetyl)-6,10,13-trimethyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-one
(6a,11b)-11,17,21-Trihydroxy-6-methylpregna-1,4-diene-3,20-dione
(6alpha,11beta)-11,17,21-Trihydroxy-6-methylpregna-1,4-diene-3,20-dione
(6α,11β)-11,17,21-trihydroxy-6-methylpregna-1,4-diene-3,20-dione
.DELTA.1-6.alpha.-Methylhydrocortisone
1-Dehydro-6alpha-methylhydrocortisone
1-dehydro-6alpha-Methylhydrocortisone
1-dehydro-6α-methylhydrocortisone
11-beta,17,21-Trihydroxy-6-alpha-methylpregna-1,4-diene-3,20-dione
11beta,17,21-Trihydroxy-6alpha-methylpregna-1,4-diene-3,20-dione
11beta,17alpha,21-Trihydroxy-6alpha-methyl-1,4-pregnadiene-3,20-dione
11beta,17alpha,21-Trihydroxy-6alpha-methylpregna-1,4-diene-3,20-dione
121673-01-6
4-08-00-03498 (Beilstein Handbook Reference)
46436_FLUKA
46436_RIEDEL
570-35-4
6 Methylprednisolone
6-Methylprednisolone
6-alpha-Methylprednisolone
6.alpha.-Methylprednisolone
6923-42-8
6alpha-Methyl-11beta,17alpha,21-trihydroxy-1,4-pregnadiene-3,20-dione
6alpha-Methyl-11beta,17alpha,21-triol-1,4-pregnadiene-3,20-dione
6alpha-Methylprednisolone
6alpha-methyl-11beta,17alpha,21-triol-1,4-pregnadiene-3,20-dione
83-43-2
AC1L1N7A
Artisone-Wyeth
Artisone-wyeth
BPBio1_000174
BRD-K35240538-001-03-1
BRN 2340300
BSPBio_000158
Besonia
Bio-0658
CHEBI:6888
CHEMBL650
CID6741
CPD000058330
D00407
D008775
DB00959
Depo-Medrol (acetate)
Dopomedrol
EINECS 201-476-4
Esametone
Firmacort
HMS1568H20
HMS2090B13
HSDB 3127
LMST02030178
LS-118498
Lemod
M0639_SIGMA
M1665
MEPRDL
MLS000028541
MLS001148159
MLS002207191
Medesone
Medixon
Medlone 21
 
Medrate
Medrol
Medrol (TN)
Medrol Adt Pak
Medrol Dosepak
Medrol adt pak
Medrol dosepak
Medrol, Solu-Medrol, Medrone, Methylprednisolone
Medrone
Mesopren
Metastab
Methyleneprednisolone
Methylprednisolon
Methylprednisolone
Methylprednisolone (JP15/USP/INN)
Methylprednisolone [USAN:INN:BAN:JAN]
Methylprednisolone, 6-alpha
Methylprednisolonum
Methylprednisolonum [INN-Latin]
Metilbetasone
Metilprednisolona
Metilprednisolona [INN-Spanish]
Metilprednisolone
Metilprednisolone [DCIT]
Metilprednisolone [Dcit]
Metipred
Metrisone
Metrocort
Metysolon
Moderin
MolPort-002-528-554
NCGC00022735-03
NCI60_001657
NSC-19987
NSC19987
Nirypan
Noretona
Predni N Tablinen
Prednol- L
Pregna-1,4-diene-3,20-dione, 11beta,17,21-trihydroxy-6alpha-methyl- (8CI)
Prestwick0_000279
Prestwick1_000279
Prestwick2_000279
Prestwick3_000279
Prestwick_622
Promacortine
Reactenol
S1733_Selleck
SAM002589984
SMR000058330
SPBio_002377
Sieropresol
Solomet
Summicort
Suprametil
U 7532
UNII-X4W7ZR7023
Urbason
Urbasone
Wyacort
ZINC03875560
delta(1)-6alpha-Methylhydrocortisone
delta(sup 1)-6-alpha-Methylhydrocortisone
methylprednisolone
methylprenisolone
26
Prednisoloneapproved, vet_approvedPhase 2119350-24-85755
Synonyms:
(11beta)-11,17,21-Trihydroxypregna-1,4-diene-3,20-dione
.DELTA.1-Cortisol
.DELTA.1-Dehydrocortisol
.DELTA.1-Dehydrohydrocortisone
.DELTA.1-Hydrocortisone
.delta.-Cortef
.delta.-Stab
1,2-Dehydrohydrocortisone
1,4-Pregnadiene-11beta,17alpha,21-triol-3,20-dione
1,4-Pregnadiene-3,20-dione-11beta,17alpha,21-triol
1-Dehydrocortisol
1-Dehydrohydrocortisone
3,20-dioxo-11beta,17alpha,21-Trihydroxy-1,4-pregnadiene
46656_FLUKA
46656_RIEDEL
50-24-8
58201-11-9
8056-11-9
AC-1773
AC1L1L2E
Ak-Pred
Ak-Tate
Alphadrol
Articulose-50
BPBio1_000164
BRD-K98039984-001-03-0
BRN 1354103
BSPBio_000148
Bio-0666
Bubbli-Pred
C07369
CCRIS 980
CHEBI:8378
CHEMBL131
CID5755
CO-Hydeltra
CPD000718761
Co-Hydeltra
Codelcortone
Cordrol
Cortalone
Cotogesic
Cotolone
D00472
D011239
DB00860
Decaprednil
Decortin H
Delcortol
Delta F
Delta(1)-dehydrohydrocortisone
Delta-Cortef
Delta-Cortef (TN)
Delta-Ef-Cortelan
Delta-Stab
Delta-stab
Deltacortenol
Deltacortril
Deltacortril Enteric
Deltahydrocortisone
Deltasolone
Deltisilone
Depo-Medrol
Derpo PD
Derpo Pd
Dexa-Cortidelt Hostacortin H
Dexa-Cortidelt hostacortin H
Di Adreson F
Di-Adreson F
Di-Adreson-F
Di-adreson F
DiAdresonF
Dicortol
Donisolone
Dydeltrone
EINECS 200-021-7
Eazolin D
Econopred
Econopred Plus
Erbacort
Erbasona
Estilsona
Fernisolone
Fernisolone P
Fernisolone-P
Flamasone
HMS1568H10
HMS2090J05
HSDB 3385
Hostacortin H
Hydeltra
Hydeltra-Tba
Hydeltrasol
Hydeltrone
Hydrodeltalone
Hydrodeltisone
Hydroretrocortin
Hydroretrocortine
I-Pred
Inflamase Forte
Inflamase Mild
K 1557
Key-Pred
Klismacort
LMST02030179
LS-7669
Lentosone
Lite Pred
M-Predrol
 
MLS001304083
MLS002154250
MLS002207037
Medrol
Medrol Acetate
Metacortandralone
Methylprednisolone Acetate
Meti-Derm
Meticortelone
Metreton
MolPort-002-507-147
NCGC00179649-01
NSC 9120
NSC9120
NSC9900
Neo-Delta-Cortef
Nisolone
Nor-Pred T.B.A.
Ocu-Pred
Ocu-Pred Forte
Ophtho-Tate
Orapred
P0152_SIGMA
P0637
P6004_SIGMA
PRDL
PRED-G
Panafcortelone
Paracortol
Paracotol
Pediapred
Poly-Pred
Precortalon
Precortancyl
Precortilon
Precortisyl
Pred Forte
Pred Mild
Predair
Predair A
Predair Forte
Predalone 50
Predalone T.B.A.
Predate
Predate Tba
Predate-50
Predcor-25
Predcor-50
Predcor-Tba
Predisolone Sodium Phosphate
Predne-Dome
Prednelan
Predni-Dome
Prednicen
Predniliderm
Predniretard
Prednis
Prednisolona
Prednisolona [INN-Spanish]
Prednisolone (JP15/USP/INN)
Prednisolone (anhydrous)
Prednisolone Acetate
Prednisolone Sodium Phosphate
Prednisolone Tebutate
Prednisolone [INN:BAN:JAN]
Prednisolonum
Prednisolonum [INN-Latin]
Predonin
Predonine
Prelone
Prenolone
Prestwick0_000274
Prestwick1_000274
Prestwick2_000274
Prestwick3_000274
Prestwick_404
Rolisone
S1737_Selleck
SAM002264639
SMR000718761
SPBio_002367
Scherisolon
Solone
Steran
Sterane
Sterolone
Supercortisol
UNII-9PHQ9Y1OLM
Ulacort
Ultra Pred
Ultracorten H
Ultracortene H
Ultracortene-H
Ultracortene-Hydrogen
Ultracortene-hydrogen
ZINC03833821
component of Ataraxoid
component of K-Predne-Dome
delta(1)-Cortisol
delta(1)-Dehydrocortisol
delta(1)-Dehydrohydrocortisone
delta(1)-Hydrocortisone
delta(sup 1)-Cortisol
delta(sup 1)-Dehydrocortisol
delta(sup 1)-Dehydrohydrocortisone
delta(sup 1)-Hydrocortisone
delta-dehydrocortisol
delta-dehydrohydrocortisone
delta-hydrocortisone
prednisolone
27
Prednisoneapproved, vet_approvedPhase 2139853-03-25865
Synonyms:
(1S,2R,10S,11S,14R,15S)-14-hydroxy-14-(2-hydroxyacetyl)-2,15-dimethyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadeca-3,6-diene-5,17-dione
(8S,9S,10R,13S,14S,17R)-17-hydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-6,7,8,9,12,14,15,16-octahydrocyclopenta[a]phenanthrene-3,11-dione
(8xi,9xi,14xi)-17,21-dihydroxypregna-1,4-diene-3,11,20-trione
.delta. E
.delta.(sup1)-Cortisone
.delta.-Cortelan
.delta.-Cortisone
.delta.-Cortone
.delta.-E
.delta.1-Cortisone
.delta.1-Dehydrocortisone
.delta.sone
1,2-Dehydrocortisone
1,4-Pregnadiene-17-alpha,21-diol-3,11,20-trione
1,4-Pregnadiene-17.alpha.,21-diol-3,11,20-trione
1,4-Pregnadiene-17alpha,21-diol-3,11,20-trione
1-Cortisone
1-Dehydrocortisone
17,21-Dihydroxypregna-1,4-diene-3,11,20-trione
17alpha,21-Dihydroxy-1,4-pregnadiene-3,11,20-trione
53-03-2
68-59-7
81552_FLUKA
AC-11112
AC1L1LB2
AC1Q29EZ
ACon0_000082
ACon1_000297
AI3-52939
Adasone
Ancortone
Apo-Prednisone
Apo-prednisone
BPBio1_000323
BRD-K85883481-001-04-2
BSPBio_000293
Betapar
Bicortone
Bio-0649
C07370
C21H26O5
CCRIS 2646
CHEBI:8382
CHEMBL635
CID5865
CPD001227202
Cartancyl
Colisone
Cortan
Cortancyl
Cortidelt
Cotone
DB00635
Dacorten
Dacortin
Decortancyl
Decortin
Decortisyl
Dehydrocortisone
Dekortin
Delcortin
Dellacort
Dellacort A
Delta Cortelan
Delta E
Delta E.
Delta-Cortelan
Delta-Dome
Delta-cortelan
Delta-cortisone
Delta-cortone
Delta-dome
Deltacortene
Deltacortisone
Deltacortone
Deltasone
Deltasone, Liquid Pred, Orasone, Adasone, Deltacortisone,Prednisone
Deltison
Deltisona
Deltisone
Deltra
Di-Adreson
Diadreson
EINECS 200-160-3
Econosone
Encorton
Encortone
Enkortolon
Enkorton
Fernisone
Fiasone
HMS1568O15
HMS2090J13
HSDB 3168
Hostacortin
In-Sone
Incocortyl
 
Juvason
Kortancyl
LMST02030180
LS-1325
Liquid Pred
Lisacort
Lodotra
MEGxm0_000443
MLS001061265
MLS001304073
MLS001335907
MLS001335908
MLS002154191
MLS002207083
Me-Korti
Metacortandracin
Meticorten
Meticorten (Veterinary)
Metrevet (Veterinary)
MolPort-001-740-041
NCGC00090766-01
NCGC00090766-02
NCGC00090766-03
NCI-C04897
NCI60_000008
NSC 10023
NSC10023
Nisona
Nizon
Novoprednisone
Nurison
Orasone
Origen Prednisone
P1276
P6254_SIGMA
PRD
Panafcort
Panasol
Paracort
Parmenison
Pehacort
Precort
Predeltin
Prednicen-M
Prednicorm
Prednicort
Prednicot
Prednidib
Prednilonga
Prednison
Prednisona
Prednisona [INN-Spanish]
Prednisone
Prednisone Intensol
Prednisone [INN:BAN]
Prednisonum
Prednisonum [INN-Latin]
Prednitone
Prednizon
Prednovister
Presone
Prestwick0_000077
Prestwick1_000077
Prestwick2_000077
Prestwick3_000077
Prestwick_405
Pronison
Pronisone
Rectodelt
Retrocortine
S1622_Selleck
SAM002264641
SK-Prednisone
SMR000718760
SMR001227202
SPBio_002214
Servisone
Sone
Sterapred
Supercortil
U 6020
UNII-VB0R961HZT
Ultracorten
Ultracortene
WLN: L E5 B666 CV OV AHTTT&J A1 E1 FV1Q FQ
Winpred
Wojtab
ZINC03875357
Zenadrid
Zenadrid (veterinary)
Zenadrid [veterinary]
delta cortelan
delta(sup 1)-Cortisone
delta(sup 1)-Dehydrocortisone
delta-1-Cortisone
delta-1-Dehydrocortisone
delta-Cortisone
delta-Cortone
28Fibrinolytic AgentsPhase 22388
29AnticoagulantsPhase 22623
30Neuroprotective AgentsPhase 21716
31Prednisolone hemisuccinatePhase 21193
32Methylprednisolone HemisuccinatePhase 21193
33Prednisolone phosphatePhase 21193
34Prednisolone acetatePhase 21193
35Peripheral Nervous System AgentsPhase 223689
36Hormone AntagonistsPhase 213180
37Antineoplastic Agents, HormonalPhase 25592
38Anti-Inflammatory AgentsPhase 210729
39AntiemeticsPhase 24022
40Antibiotics, AntitubercularPhase 27180
41Autonomic AgentsPhase 210150
42Gastrointestinal AgentsPhase 28402
43Immunosuppressive AgentsPhase 213086
44Hormones, Hormone Substitutes, and Hormone AntagonistsPhase 213168
45HormonesPhase 214415
46Methylprednisolone acetatePhase 21193
47glucocorticoidsPhase 25103
48Immunoglobulin MPhase 19
49Immunoglobulin GPhase 1275
50AutoantibodiesPhase 1130

Interventional clinical trials:

(show top 50)    (show all 133)
idNameStatusNCT IDPhase
1The Safety and Immunogenicity Study of Rotavirus Vaccine Simultaneously Vaccinated With MR or MMR VaccineUnknown statusNCT02153866Phase 4
2Coadministration of Measles-rubella and Rotavirus VaccinesCompletedNCT01700621Phase 4
3Immunogenicity and Safety of Combined Vaccine to Prevent Measles, Mumps, Rubella and Chickenpox DiseasesCompletedNCT00126997Phase 4
4Safety and Efficacy of Measles, Mumps, Rubella Vaccination in Juvenile Idiopathic ArthritisCompletedNCT00731965Phase 4
5Study on Immunization Schedule of Beijing Tiantan Biological's Measles-mumps-rubella(MMR) VaccineCompletedNCT03160820Phase 4
6Comparative Study of the Immunogenicity of MMR (Measles, Mumps and Rubella) Single Dose and Multidose PresentationsCompletedNCT01777529Phase 4
7Immunogenicity and Safety of Hepatitis A Vaccine Given at the Same Time of Measles, Mumps, Rubella Combined VaccineCompletedNCT00313950Phase 4
8Immunogenicity of Co-administration of Measles and Japanese Encephalitis VaccinesCompletedNCT02643433Phase 4
9Measles, Mumps, and Rubella (MMR) Immunity in College StudentsCompletedNCT00962819Phase 4
10MMR Vaccination Among HIV-infected AdultsCompletedNCT02724852Phase 4
11Hepatitis A Vaccine, Inactivated and Measles, Mumps, Rubella and Varicella Virus Vaccine Live Safety Study (V251-066)(COMPLETED)CompletedNCT00326183Phase 4
12Assess GSK Biologicals' MMR Vaccine (Priorix) When Given to Healthy Children at the Age of 12 to 18 Months in Singapore.CompletedNCT00388440Phase 4
13Concomitant Use of Hepatitis A Vaccine With Measles, Mumps, Rubella and Varicella Vaccine and Pneumococcal 7-Valent Conjugate Vaccine in Healthy 12-Month-Old Children (V251-067)CompletedNCT00312858Phase 4
14IPV Clinical Trial - The GambiaCompletedNCT01847872Phase 4
15MMR and Varicella Vaccine in Premature InfantsCompletedNCT00156559Phase 4
16Safety Study of a Refrigerator-stable Formulation of VARIVAX®CompletedNCT00432731Phase 4
17Safety & Immunogenicity of MMR Vaccine by DSJI to That by Needle-Syringe in 15-18 Months Old ChildrenCompletedNCT02253407Phase 4
18Study of the Influence of Vaccination in HIV Viral Load and Immunologic Responses Against HIVCompletedNCT00329251Phase 4
19Immunogenicity and Safety of Japanese Encephalitis Vaccine When Given With Measles-Mumps-Rubella VaccineRecruitingNCT02880865Phase 4
20Homeopathic Vaccine TrialRecruitingNCT02825368Phase 4
21Induction of Immunity Against Measles in Pediatric Liver Transplant RecipientsRecruitingNCT01770119Phase 4
22Search for the Measles Vaccine Virus Excretion in Breast Milk of Breastfeeding Women After Postpartum Vaccination With MMRActive, not recruitingNCT02325310Phase 4
23Measles-Rubella Vaccine Immunogenicity at 6 and 9 Months of AgeNot yet recruitingNCT03071575Phase 4
24Responses of Premature Infants to Measles-Mumps-Rubella (MMR) and Varicella VaccinesTerminatedNCT00138255Phase 4
25Immunogenicity and Reactogenicity of a Trivalent MMR (Trivivac) in Healthy InfantsUnknown statusNCT01763268Phase 2, Phase 3
26Immunogenicity and Safety of a Combined Vaccine to Prevent Measles, Mumps, Rubella and Chickenpox DiseasesCompletedNCT00127010Phase 3
27Immunogenicity and Safety of a Combined Vaccine to Prevent Measles, Mumps, Rubella and Chickenpox DiseasesCompletedNCT00127023Phase 3
28Immunogenicity and Safety of GSK Biologicals' Combined Measles-mumps-rubella Vaccine in Volunteers, Seven Years of Age and OlderCompletedNCT02058563Phase 3
29Study of Japanese Encephalitis Chimeric Virus Vaccine Given With Measles-Mumps-Rubella Vaccine in Taiwanese ToddlersCompletedNCT01188343Phase 3
30Safety, Tolerability, and Immunogenicity of Measles, Mumps, Rubella, and Varicella (MMRV) Vaccine Made With an Alternative Manufacturing Process (AMP)(V221-027)CompletedNCT01536405Phase 3
31Study to Evaluate Frozen Versus Refrigerated MMRV (Combined Measles, Mumps, Rubella, and Varicella) Investigational Vaccine (V221-016)CompletedNCT00092430Phase 3
32Study of Immunogenicity, Reactogenicity and Safety of the Combined Measles, Mumps and Rubella Vaccine Produced by Bio-Manguinhos/Fiocruz in Children 12-15 Months of Age, Followed by Tetraviral Vaccine in Children 15-18 Months.CompletedNCT01991899Phase 3
33Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Combined Measles-mumps-rubella (MMR) Vaccine in Children in Their Second Year of LifeCompletedNCT01681992Phase 3
34Safety and Immunogenicity Study of GlaxoSmithKline (GSK) Biologicals' Measles, Mumps and Rubella (MMR) Vaccine (209762) Compared to Merck & Co., Inc.'s MMR Vaccine in Healthy Children 12 to 15 Months of AgeCompletedNCT02184572Phase 3
35Immunogenicity & Safety Study of GSK Biologicals' Combined Measles-mumps-rubella-varicella Vaccine 208136CompletedNCT00751348Phase 3
36Trial to Assess Safety, Tolerability, and Immunogenicity of Influenza Virus Vaccine, Trivalent, Types A & B, Live Cold-Adapted (FluMist) and Measles, Mumps, Rubella, and Varicella Vaccines Administered Concurrently to Healthy ChildrenCompletedNCT00192491Phase 3
37Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Combined Measles-mumps-rubella (MMR) Vaccine in Subjects Four to Six Years of AgeCompletedNCT01621802Phase 3
38Immunogenicity & Safety of Hepatitis A Vaccine Co-admin With a Measles/Mumps/Rubella & a Varicella Vaccine in ChildrenCompletedNCT00197015Phase 3
39Evaluate Vaccine Against Chickenpox and a Combined Vaccine Against 4 Viral Childhood Diseases: Measles, Mumps, Rubella and ChickenpoxCompletedNCT00226499Phase 3
40Immunogenicity and Safety Study of PriorixTetra™ When Co-administered With Conjugated MenC Vaccine in Healthy ChildrenCompletedNCT01506193Phase 3
41ProQuad™ Versus M-M-R II™ and VARIVAX™ in Healthy Children (V221-009)(COMPLETED)CompletedNCT00975507Phase 3
42ProQuad® rHA SafetyCompletedNCT00560755Phase 3
43Comparison of GSK Measles-mumps-rubella-varicella (MMRV) Vaccine Versus PriorixTMCompletedNCT00969436Phase 3
44Consistency Study of GlaxoSmithKline (GSK) Biologicals' MMR Vaccine (209762) (Priorix®) Comparing Immunogenicity and Safety to Merck & Co., Inc.'s MMR Vaccine (M M R®II), in Children 12 to 15 Months of AgeCompletedNCT01702428Phase 3
45ProQuad® Intramuscular vs SubcutaneousCompletedNCT00402831Phase 3
46Immunogenicity and Safety Study of Proquad® and Infanrix® Hexa When Administered ConcomitantlyCompletedNCT00432042Phase 3
47Long-term Follow-up on Immunogenicity & Safety of Measles-Mumps-Rubella-Varicella (MMRV) Combined VaccineCompletedNCT00406211Phase 3
48Safety, Tolerability, and Immunogenicity of 3 Frozen ProQuad Consistency Lots in Healthy Children (V221-012)(COMPLETED)CompletedNCT00985153Phase 3
49A Study of ProQuad in Healthy 4 to 6 Year Old Children (V221-014)CompletedNCT00985166Phase 3
50Immunogenicity and Safety of Pediatric Vaccines When Administered With Menactra® in Healthy ToddlersCompletedNCT00422292Phase 3

Search NIH Clinical Center for Rubella


Cochrane evidence based reviews: rubella

Genetic Tests for Rubella

About this section

Anatomical Context for Rubella

About this section

MalaCards organs/tissues related to Rubella:

36
Skin, Eye, Brain, Heart, Lymph node, Testes, T cells

FMA organs/tissues related to Rubella:

17
Skin

Publications for Rubella

About this section

Articles related to Rubella:

(show top 50)    (show all 1244)
idTitleAuthorsYear
1
Hospital-based surveillance of congenital rubella syndrome in Indonesia. (28091778)
2017
2
Susceptibility of Rubella Among Pregnant Women Attending the Antenatal Clinic in a Tertiary Care Hospital, Jabalpur, Central India. (27925863)
2017
3
Pancreatic pseudocyst after measles, mumps, and rubella vaccination. (28082255)
2017
4
FUNDUS AUTOFLUORESCENCE IN RUBELLA RETINOPATHY: Correlation With Photoreceptor Structure and Function. (28005720)
2017
5
Cutaneous and Visceral Chronic Granulomatous Disease Triggered by a Rubella Virus Vaccine Strain in Children With Primary Immunodeficiencies. (27810866)
2017
6
The end of measles and congenital rubella: an achievable dream? (28067934)
2017
7
Economic impact of switching rubella IgG methodologies to the prenatal public health program in Alberta. (27567094)
2016
8
Mumps Outbreak at a University and Recommendation for a Third Dose of Measles-Mumps-Rubella Vaccine - Illinois, 2015-2016. (27467572)
2016
9
Seroprevalences of Specific IgG Antibodies to Measles, Mumps, and Rubella in Korean Infants. (27822935)
2016
10
Global measles and rubella laboratory network support for elimination goals, 2010a892015. (27156255)
2016
11
Assessing immunity to rubella virus: a plea for standardization of IgG (immuno)assays. (27147722)
2016
12
Determinants of European parents' decision on the vaccination of their children against measles, mumps and rubella: A systematic review and meta-analysis. (27163657)
2016
13
Analysis of complete genomes of the rubella virus genotypes 1E and 2B which circulated in China, 2000-2013. (27959338)
2016
14
Zika Virus Is More Like Rubella Than Human Immunodeficiency Virus-Reply. (27617894)
2016
15
Measles and Rubella Seroprevalence Among HIV-Infected And Uninfected Zambian Youth. (27879554)
2016
16
Congenital Rubella. (27732820)
2016
17
Using the two-source capture-recapture method to estimate the incidence and case ascertainment of congenital rubella syndrome in Australia, 1993-2013. (27757254)
2016
18
Corrigendum to "Evaluation of sensitivity of TaqMan RT-PCR for rubella virus detection in clinical specimens" [J. Clin. Virol. 80 (2016) 98-101]. (27523613)
2016
19
Epidemiology of rubella virus cases in the pre-vaccination era of Ethiopia, 2009-2015. (27863513)
2016
20
Vaccine-Preventable Diseases In Pediatric Patients: A Review Of Measles, Mumps, Rubella, And Varicella. (27893360)
2016
21
Measles, mumps, rubella, and varicella seroprevalence in refugees in Germany in 2015. (27449329)
2016
22
Estimating the burden of rubella virus infection and congenital rubella syndrome through a rubella immunity assessment among pregnant women in the Democratic Republic of the Congo: Potential impact on vaccination policy. (27866768)
2016
23
An outbreak investigation of congenital rubella syndrome in Solomon Islands, 2013. (27757248)
2016
24
Vaccination in secondary school students expedites rubella control and prevents congenital rubella syndrome. (27899091)
2016
25
Spectral Domain-Optical Coherence Tomography Findings in Unilateral Rubella Retinopathy. (27579589)
2016
26
Measles & rubella outbreaks in Maharashtra State, India. (27121521)
2016
27
Global Measles and Rubella Laboratory Network Support for Elimination Goals, 2010-2015. (27148917)
2016
28
Measles-Mumps-Rubella vaccine for children with egg allergy: Is admission for inpatient vaccination necessary? (27770112)
2016
29
Congenital Rubella Syndrome: A Case Report on Changes in Viral Load and Rubella Antibody Titers. (27244797)
2016
30
Calcium-dependent Rubella Virus Fusion Occurs in Early Endosomes. (27122589)
2016
31
Unilateral Optic Neuritis: A Rare Complication after Measles-Mumps-Rubella Vaccination in a 30-Year-Old Woman. (27195163)
2016
32
Introduction of rubella-containing-vaccine to Madagascar: implications for roll-out and local elimination. (27122178)
2016
33
Localization of Viral Antigens Improves Understanding of Congenital Rubella Syndrome Pathophysiology. (26870811)
2016
34
Anti-rubella, Mumps and Measles IgG Antibodies in Medical Students of Tehran University. (27424140)
2016
35
Scale-Free Distribution of Local Infection Cluster Sizes of Measles, Rubella, Syphilis and HIV/AIDS: Correlation with Size Distribution of Municipality Population That Was Also Scale-Free. (27169948)
2016
36
Evaluation of impact of measles rubella campaign on vaccination coverage and routine immunization services in Bangladesh. (27519586)
2016
37
Antiviral activity of hemolymph of Podalia against rubella virus. (27896559)
2016
38
Psychiatric manifestations of congenital rubella syndrome: A case report and review of literature. (27606025)
2016
39
Is birth cohort 1985/9-1990/8 a susceptibility window for congenital rubella syndrome in Taiwan? (27343317)
2016
40
Laboratory confirmation of rubella infection in suspected measles cases. (27018071)
2016
41
Aseptic meningitis after measles-mumps-rubella (MMR) vaccination. (27181175)
2016
42
Seroprevalence of antibodies to measles, mumps, and rubella, and serologic responses after vaccination among human immunodeficiency virus (HIV)-1 infected adults in Northern Thailand. (27138005)
2016
43
Inhibitory Activities of Phenolic Compounds Isolated from Adina rubella Leaves Against 5I+-Reductase Associated with Benign Prostatic Hypertrophy. (27399661)
2016
44
Rubella Immunity in Pregnant Native Taiwanese and Immigrants from Asian Countries. (27895276)
2016
45
Fetal malformation in maternal toxoplasma and rubella co-infection in Cameroon: a case report. (27912790)
2016
46
High levels of susceptibility to measles, mumps and rubella (MMR) in HIV-infected individuals in Ireland. (27118245)
2016
47
A case of congenital rubella syndrome and infection in South-East London in 2015: prevention, diagnosis, and the public health response. (27884915)
2016
48
A double blind, randomized, active controlled study to assess the safety, tolerability and immunogenicity of measles, mumps rubella, and varicella vaccine (MMRV) manufactured using an alternative process. (27149048)
2016
49
Mumps, measles and rubella vaccination in children with PFAPA syndrome. (27997341)
2016
50
Rubella persistence in epidermal keratinocytes and granuloma M2 macrophages in patients with primary immunodeficiencies. (27613149)
2016

Variations for Rubella

About this section

Expression for genes affiliated with Rubella

About this section
Search GEO for disease gene expression data for Rubella.

Pathways for genes affiliated with Rubella

About this section

Pathways related to Rubella according to GeneCards Suite gene sharing:

(show all 29)
idSuper pathwaysScoreTop Affiliating Genes
19.4CD40LG, HLA-A, HLA-B
29.4CALR, HLA-A, HLA-B
39.1HLA-DPB1, HLA-DQB1, HLA-DRB1
49.1HLA-DPB1, HLA-DQB1, HLA-DRB1
5
Show member pathways
9.1HLA-DPB1, HLA-DQB1, HLA-DRB1
6
Show member pathways
8.9CD40LG, IL4, TNF
78.9CD40LG, IL4, TNF
8
Show member pathways
8.8HLA-A, HLA-DRB1, IL4
98.8IL10RB, IL4, TNF
108.7HLA-DRB1, IL4, TNF
118.6C1QBP, CD40LG, IL4, TNF
128.6HLA-DPB1, HLA-DQB1, HLA-DRB1, TNF
13
Show member pathways
8.3HLA-A, HLA-B, IL4, TNF
14
Show member pathways
8.3HLA-A, HLA-B, IL4, TNF
158.3HLA-DPB1, HLA-DQB1, HLA-DRB1, IL10RB, TNF
168.1CD40LG, HLA-A, HLA-B, HLA-DPB1, HLA-DQB1, HLA-DRB1
178.0CALR, HLA-A, HLA-B, HLA-DPB1, HLA-DQB1, HLA-DRB1
187.9HLA-A, HLA-B, HLA-DPB1, HLA-DQB1, HLA-DRB1, IL10RB
19
Show member pathways
7.8CALR, CD40LG, HLA-A, HLA-B, HLA-DPB1, HLA-DQB1
207.8HLA-DPB1, HLA-DQB1, HLA-DRB1, IL4, TNF
21
Show member pathways
7.7HLA-A, HLA-B, HLA-DPB1, HLA-DQB1, HLA-DRB1, TRIM22
227.5CALR, HLA-A, HLA-B, HLA-DPB1, HLA-DQB1, HLA-DRB1
23
Show member pathways
7.4HLA-DPB1, HLA-DQB1, HLA-DRB1, IL10RB, IL4, TNF
24
Show member pathways
7.2CD40LG, HLA-DPB1, HLA-DQB1, HLA-DRB1, IL10RB, IL4
25
Show member pathways
7.2CD40LG, HLA-DPB1, HLA-DQB1, HLA-DRB1, IL10RB, IL4
26
Show member pathways
6.7C1QBP, HLA-A, HLA-B, HLA-DPB1, HLA-DQB1, HLA-DRB1
27
Show member pathways
5.9CALR, CD40LG, HLA-A, HLA-B, HLA-DPB1, HLA-DQB1
28
Show member pathways
5.8CD40LG, HLA-A, HLA-B, HLA-DPB1, HLA-DQB1, HLA-DRB1
29
Show member pathways
5.5CALR, CD40LG, HLA-A, HLA-B, HLA-DPB1, HLA-DQB1

GO Terms for genes affiliated with Rubella

About this section

Cellular components related to Rubella according to GeneCards Suite gene sharing:

(show all 13)
idNameGO IDScoreTop Affiliating Genes
1MHC class I protein complexGO:004261210.4HLA-A, HLA-B
2phagocytic vesicle membraneGO:003067010.2CALR, HLA-A, HLA-B
3clathrin-coated endocytic vesicle membraneGO:00306699.9HLA-DPB1, HLA-DQB1, HLA-DRB1
4endocytic vesicle membraneGO:00306669.9HLA-DPB1, HLA-DQB1, HLA-DRB1
5MHC class II protein complexGO:00426139.9HLA-DPB1, HLA-DQB1, HLA-DRB1
6trans-Golgi network membraneGO:00325889.6HLA-DPB1, HLA-DQB1, HLA-DRB1
7transport vesicle membraneGO:00306589.1HLA-DPB1, HLA-DQB1, HLA-DRB1
8ER to Golgi transport vesicle membraneGO:00125079.1HLA-A, HLA-B, HLA-DPB1, HLA-DQB1, HLA-DRB1
9Golgi membraneGO:00001399.1HLA-A, HLA-B, HLA-DPB1, HLA-DQB1, HLA-DRB1
10external side of plasma membraneGO:00098979.0CALR, CD40LG, HLA-DRB1, IL4, TNF
11integral component of lumenal side of endoplasmic reticulum membraneGO:00715568.8CALR, HLA-A, HLA-B, HLA-DPB1, HLA-DQB1, HLA-DRB1
12cell surfaceGO:00099867.9C1QBP, CALR, CD40LG, HLA-A, HLA-B, HLA-DPB1
13plasma membraneGO:00058866.7C1QBP, CD40LG, HLA-A, HLA-B, HLA-DPB1, HLA-DQB1

Biological processes related to Rubella according to GeneCards Suite gene sharing:

(show all 23)
idNameGO IDScoreTop Affiliating Genes
1positive regulation of dendritic cell chemotaxisGO:200051010.7C1QBP, CALR
2antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independentGO:000248010.4HLA-A, HLA-B
3positive regulation of NIK/NF-kappaB signalingGO:190122410.4CALR, TNF
4regulation of immunoglobulin secretionGO:005102310.4CD40LG, TNF
5protection from natural killer cell mediated cytotoxicityGO:004227010.3HLA-A, HLA-B
6humoral immune response mediated by circulating immunoglobulinGO:000245510.2HLA-DQB1, HLA-DRB1
7immunoglobulin production involved in immunoglobulin mediated immune responseGO:000238110.2HLA-DQB1, HLA-DRB1
8antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependentGO:000247910.1CALR, HLA-A, HLA-B
9antigen processing and presentation of peptide antigen via MHC class IGO:000247410.1CALR, HLA-A, HLA-B
10antigen processing and presentation of exogenous peptide antigen via MHC class IIGO:00198869.9HLA-DPB1, HLA-DQB1, HLA-DRB1
11antigen processing and presentation of peptide or polysaccharide antigen via MHC class IIGO:00025049.9HLA-DPB1, HLA-DQB1, HLA-DRB1
12positive regulation of chemokine biosynthetic processGO:00450809.8IL4, TNF
13positive regulation of mononuclear cell migrationGO:00716779.8IL4, TNF
14positive regulation of NF-kappaB transcription factor activityGO:00510929.8CD40LG, TNF, TRIM22, TRIM5
15positive regulation of T cell proliferationGO:00421029.8CD40LG, HLA-DPB1, IL4
16T cell costimulationGO:00312959.5CD40LG, HLA-DPB1, HLA-DQB1, HLA-DRB1
17regulation of immune responseGO:00507769.2CD40LG, HLA-A, HLA-B, IL4
18positive regulation of sequence-specific DNA binding transcription factor activityGO:00510919.2IL4, TNF, TRIM22, TRIM5
19immune system processGO:00023769.1C1QBP, HLA-A, HLA-B, HLA-DPB1, HLA-DRB1, TRIM5
20antigen processing and presentationGO:00198829.0HLA-A, HLA-B, HLA-DPB1, HLA-DQB1, HLA-DRB1
21interferon-gamma-mediated signaling pathwayGO:00603338.4HLA-A, HLA-B, HLA-DPB1, HLA-DQB1, HLA-DRB1, TRIM22
22viral processGO:00160328.1C1QBP, HLA-A, HLA-B, HLA-DRB1, MOG, TRIM22
23immune responseGO:00069556.5C1QBP, CD40LG, HLA-A, HLA-B, HLA-DPB1, HLA-DQB1

Molecular functions related to Rubella according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1complement component C1q bindingGO:000184910.4C1QBP, CALR
2MHC class II receptor activityGO:00323959.8HLA-DQB1, HLA-DRB1
3peptide antigen bindingGO:00426058.3HLA-A, HLA-B, HLA-DPB1, HLA-DQB1, HLA-DRB1

Sources for Rubella

About this section
2CDC
6CNVD
10DGIdb
15ExPASy
16FDA
17FMA
27GTR
28HGMD
29HMDB
30ICD10
31ICD10 via Orphanet
32ICD9CM
33IUPHAR
34KEGG
37MedGen
39MeSH
40MESH via Orphanet
41MGI
44NCI
45NCIt
46NDF-RT
49NINDS
50Novoseek
52OMIM
53OMIM via Orphanet
57PubMed
58QIAGEN
63SNOMED-CT via Orphanet
67Tumor Gene Family of Databases
68UMLS
69UMLS via Orphanet